Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Beam ...

With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...